Marijuana can be consumed in more ways than most people realize, and each method changes how quickly the drug takes effect, how long it lasts, and what health risks come along for the ride. The most common routes are smoking, vaping, eating edibles, and applying topical products, but within those broad categories sit dozens of variations, from sublingual tinctures to transdermal patches to high-temperature dabbing rigs. How you consume cannabis is not just a matter of preference; it shapes the pharmacology of what your body actually absorbs and the specific harms you face.
Smoking and Other Combustion Methods
Joints, pipes, bongs, and blunts all work the same fundamental way: plant material burns, and you inhale the smoke. THC enters the bloodstream through the lungs rapidly, reaching peak blood levels within about six to ten minutes. The bioavailability of inhaled THC ranges from roughly 10% to 35%, depending on how deeply and how long you inhale, and how much THC is in the product.1PubMed Central. Mechanisms of Action and Pharmacokinetics of Cannabis One pharmacokinetic study found that smoking a relatively low-potency joint (about 3.5% THC) produced an average peak plasma level of around 150 ng/mL within ten minutes.2PubMed. Pharmacokinetics of cannabinoids That fast onset is part of why smoking remains the most popular consumption method: users feel the effects almost immediately and can adjust their intake puff by puff.
The tradeoff is combustion itself. Burning cannabis generates many of the same irritants found in tobacco smoke. Chronic smoking is linked to cough, excess sputum, and wheezing, a pattern that resembles chronic bronchitis.3PubMed Central. Cannabis use and its impact on respiratory physiology and lung cancer risk: Mechanistic and epidemiological insights These symptoms tend to improve once someone stops smoking, suggesting that the airway irritation is inflammatory rather than permanently structural.4PubMed. Marijuana and lung diseases Water pipes and bongs cool the smoke, which may feel less harsh, but they do not meaningfully filter out the tar, particulate matter, or carbon monoxide that cause the respiratory problems.
Vaping Cannabis
Vaporizers heat cannabis flower or oil to a temperature below combustion, producing an aerosol rather than smoke. In theory, this reduces the tar and combustion byproducts you inhale. In practice, vaping introduces its own set of concerns, especially with oil-based cartridge devices.
The 2019 outbreak of lung injuries known as EVALI made this brutally clear. Thousands of cases of severe lung illness and dozens of deaths were linked to vaping THC-containing e-liquids, many of them obtained outside regulated markets.5PubMed. Vaping Aerosols from Vitamin E Acetate and Tetrahydrocannabinol Oil: Chemistry and Composition Vitamin E acetate (VEA), a thickening agent used as a cheap cutting agent in illicit THC cartridges, emerged as the leading suspect. Lab studies show that airway cells exposed to aerosols containing CBD oil and VEA suffer striking rates of cell death: roughly 45% dead cells after repeated CBD oil exposure, climbing to about 60% when VEA was added.6PubMed Central. Vaping Additives Cannabinoid Oil and Vitamin E Acetate Adhere to and Damage the Human Airway Epithelium Even after the EVALI outbreak prompted some cleanup, cases have continued to surface, and reviews of the broader landscape point to ongoing risks from contaminants, heavy metals, and flavoring agents in unregulated hemp-derived vaping products that flooded the market after the 2018 U.S. Farm Bill.7PubMed Central. Cannabinoid Vaping Products: Regulation, Composition, Toxicological Effects, and Emerging Research
Dabbing and High-Potency Concentrates
Dabbing involves flash-vaporizing a small amount of cannabis concentrate, typically containing 60% to 90% THC, on a superheated surface and inhaling the resulting vapor. The intense heat is the problem. When terpenes in concentrates are heated to temperatures between 300°C and 500°C, they break down into toxic byproducts. Chemical analyses have found that dabbing generates notable levels of benzene and methacrolein, both recognized toxicants.8PubMed Central. Toxicant Formation in Dabbing: The Terpene Story THC itself, when heated to dabbing temperatures with or without added terpenes, produces degradation products including methacrolein, methyl vinyl ketone, and elevated levels of isoprene.9PubMed Central. Aerosol Gas-Phase Components from Cannabis E-Cigarettes and Dabbing: Mechanistic Insight and Quantitative Risk Analysis
Beyond the chemical exposure, the sheer potency of concentrates means users can ingest very large doses of THC in a single hit. Experienced smokers sometimes tolerate this, but for anyone without significant tolerance, the result can be overwhelming anxiety, paranoia, or vomiting. The release of ultrafine particles during heating is another concern: one chamber study found that large quantities of ultrafine particles were released upon heating terpene mixtures and remained airborne for at least three hours.10PubMed. Emissions from Heated Terpenoids Present in Vaporizable Cannabis Concentrates
Edibles
Cannabis-infused foods and drinks take a fundamentally different pharmacological route than inhalation. THC is absorbed through the gut and passes through the liver before reaching the brain, a process called first-pass metabolism. This converts a portion of THC into 11-hydroxy-THC, an active metabolite that crosses the blood-brain barrier more easily. The result is a high that typically feels stronger and lasts longer than smoking, but that takes anywhere from 30 minutes to two hours to kick in. That delay is the single biggest source of trouble with edibles: people eat a dose, feel nothing, eat more, and then find themselves far more intoxicated than intended once it all kicks in at once.
What you eat alongside edibles matters more than most people know. A study examining THC capsules found that consuming them with a high-fat meal significantly increased both peak blood levels and total drug exposure compared to taking them on an empty stomach.11PubMed Central. Human Pharmacokinetic Parameters of Orally Administered Δ9-Tetrahydrocannabinol Capsules Are Altered by Fed Versus Fasted Conditions and Sex Differences The same study found that women reached higher peak plasma concentrations than men at the same dose when fasting, adding another layer of individual variability that makes dosing edibles unpredictable.
Pediatric Edible Exposures
Cannabis edibles often look identical to regular candy, gummies, or baked goods, and children cannot tell the difference. Poison control data show that pediatric exposures have skyrocketed: reported cases of edible cannabis ingestion in children rose from 207 in 2017 to over 3,000 in 2021, an increase of roughly 1,375%.12Pediatrics. Pediatric Edible Cannabis Exposures and Acute Toxicity: 2017–2021 About 70% of cases that were followed showed central nervous system depression, and nearly 23% of patients were admitted to the hospital.
In children, common symptoms after accidental ingestion include altered consciousness, irritability, low muscle tone, and lethargy. Serious outcomes like coma and seizures are rare but do occur. A Canadian review found that about 88% of pediatric cases involved edible products such as gummies, candies, or chocolates, and that some children required ICU stays or mechanical ventilation, though no deaths were reported in that dataset.13BC Medical Journal. Unintentional cannabis exposure in children: Clinical presentations, management, and outcomes Children are at higher risk of severe symptoms like respiratory depression and seizures than adults because of their smaller body weight and developing nervous systems.14PubMed Central. Accidental cannabis ingestion in young children
Sublingual and Mucosal Products
Tinctures, sprays, and strips placed under the tongue or against the inside of the cheek are designed to deliver cannabinoids through the mucous membranes, bypassing the gut and liver. This approach aims for a middle ground: faster onset than edibles, less lung exposure than smoking. Research on sublingual delivery has shown real promise for improving bioavailability. An animal study comparing sublingual THC to oral THC found that sublingual delivery achieved an absolute bioavailability of about 16%, compared to roughly 1.3% for oral administration of an equivalent dose, though that particular formulation used a cyclodextrin complex to enhance absorption.15PubMed Central. Sublingual administration of Delta9-tetrahydrocannabinol/beta-cyclodextrin complex increases the bioavailability of Delta9-tetrahydrocannabinol in rabbits Real-world sublingual products vary widely in how well they work, and many users end up swallowing some of the tincture, which means part of the dose follows the slower oral route anyway.
Topicals and Transdermal Patches
Cannabis-infused creams, balms, and lotions applied to the skin are generally intended for localized relief of pain or inflammation, not for a psychoactive high. Cannabinoids are lipophilic but have difficulty crossing the skin’s outermost barrier efficiently. Research using human skin samples found that CBD absorption into the skin did not significantly increase when the concentration was raised from 5% to 10%, suggesting a ceiling effect for passive skin delivery, though the addition of certain chemical enhancers like oleic acid roughly quadrupled the amount that penetrated.16PubMed. In vitro percutaneous absorption studies of cannabidiol using human skin: Exploring the effect of drug concentration, chemical enhancers, and essential oils
Transdermal patches, in contrast, are engineered to push cannabinoids through the skin and into the bloodstream. One clinical study of a novel transdermal system found that both CBD and THC reached measurable systemic levels, with peak concentrations occurring around eight hours after application and levels still detectable at 12 hours.17PubMed Central. Examining the Systemic Bioavailability of Cannabidiol and Tetrahydrocannabinol from a Novel Transdermal Delivery System in Healthy Adults: A Single-Arm, Open-Label, Exploratory Study That slow, sustained release is the appeal of patches: they offer steady blood levels without the spikes and troughs of smoking or edibles, though the total amount absorbed tends to be quite low.
Cardiovascular Risks Across Methods
THC affects the cardiovascular system regardless of how it enters the body. It typically raises heart rate acutely, and in some people it triggers notable drops in blood pressure upon standing. A review of the available literature identified three major cardiovascular effects: a condition sometimes called “cannabis arteritis” (inflammation of blood vessels), vasospasms triggered by cannabis, and increased platelet clumping that could theoretically contribute to clot formation.18PubMed Central. The Cardiovascular Effects of Marijuana: Are the Potential Adverse Effects Worth the High? Whether long-term cannabis use accelerates atherosclerosis remains unresolved. For people with existing heart conditions, the acute heart-rate increase after smoking or dabbing can be clinically meaningful and is a reason cardiologists tend to advise caution.
Cannabinoid Hyperemesis Syndrome
One of the stranger risks of heavy, long-term cannabis use is cannabinoid hyperemesis syndrome (CHS), a condition marked by severe, cyclic bouts of nausea and vomiting that can last hours. The hallmark behavior is compulsive hot bathing, which temporarily eases symptoms for reasons researchers are still working out. Current evidence points to the idea that prolonged high-dose THC exposure dysregulates the body’s own endocannabinoid system via CB1 receptors, which in turn disrupts thermoregulation, stress responses, and several neurotransmitter pathways.19PubMed Central. Cannabinoid Hyperemesis Syndrome: A Review of Potential Mechanisms CHS is frequently misdiagnosed as cyclic vomiting syndrome, and many patients go through rounds of expensive testing before the connection to cannabis is identified. The only reliable treatment is stopping cannabis use entirely.
Synthetic Cannabinoids
Products sold under names like K2 and Spice contain lab-made chemicals that bind to the same brain receptors as THC but are far more potent. Synthetic cannabinoids can have receptor affinity roughly 100 times greater than natural cannabis, and that potency translates directly into more dangerous outcomes: psychosis, seizures, muscle breakdown (rhabdomyolysis), and severe cardiovascular events.20PubMed. Adverse clinical effects associated with the use of synthetic cannabinoids: A systematic review Unlike plant-derived cannabis, where THC is a partial agonist at CB1 receptors, many synthetic cannabinoids are full agonists, meaning they activate the receptor to a much greater degree with no built-in ceiling. The clinical picture is accordingly more severe: synthetic cannabinoid users show higher rates of positive psychotic symptoms and poorer recovery compared to people who use natural cannabis.21PubMed. Alexithymia and psychopathological dimensions in First-Episode Psychosis: Comparative patterns in natural cannabis versus synthetic cannabinoid users These products should be considered an entirely different drug category from plant cannabis despite sharing the “cannabinoid” label.
Tolerance, Dependence, and Withdrawal
Frequent cannabis use causes measurable changes in the brain. Imaging studies of daily smokers show that CB1 receptor availability in the cortex drops by about 20% compared to non-users, and the longer someone has smoked, the more pronounced that reduction tends to be.22PubMed Central. Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers This downregulation is the biological basis for tolerance: your brain has fewer receptors available, so the same dose produces less effect, and you need more to get the same result.
The encouraging finding is that this process is largely reversible. A study tracking cannabis-dependent individuals found that after just two days of abstinence, CB1 receptor availability was no longer significantly different from non-users, and after about four weeks of abstinence the recovery was essentially complete across brain regions.23PubMed Central. Rapid Changes in CB1 Receptor Availability in Cannabis Dependent Males after Abstinence from Cannabis Animal research suggests that receptor signaling at the protein level takes somewhat longer to fully normalize, particularly in the hippocampus compared to other brain regions.24Molecular Pharmacology. Mechanisms of Cannabinoid CB1 Receptor Down-Regulation and Desensitization in Tolerant Mice
Cannabis withdrawal is real and pharmacologically specific, though it is less dramatic than withdrawal from alcohol or opioids. Irritability, sleep disruption, decreased appetite, anxiety, and cravings are the core symptoms. Both animal and human studies confirm that giving a CB1 agonist (THC) relieves withdrawal symptoms, solidifying that this is a genuine neurochemical process and not just a psychological habit.25PubMed Central. Clinical management of cannabis withdrawal
Drug Interactions
Both THC and CBD are processed in the liver by the same family of enzymes that metabolize a long list of common medications. CBD in particular is a potent inhibitor of CYP2C19 and CYP3A4, two enzymes responsible for breaking down drugs ranging from blood thinners to antidepressants to certain heart medications.26PubMed. Neuropsychiatric and General Interactions of Natural and Synthetic Cannabinoids with Drugs of Abuse and Medicines When CBD slows down these enzymes, drugs that depend on them for clearance can build up in your system to higher-than-intended levels. This is a particular concern for people taking seizure medications, blood thinners like warfarin, or immunosuppressants. If you use cannabis products regularly and take prescription drugs, this is worth discussing with your pharmacist or physician.
Contaminants in Unregulated Products
What is in the product matters as much as how you consume it. A Canadian study comparing legal and illegal cannabis found stark differences. Among illegal samples, 94% contained pesticide residues averaging 3.4 different compounds per sample, 73% exceeded yeast and mold limits, 55% exceeded aerobic bacteria thresholds, and 12% contained detectable mycotoxins. Legal products were far cleaner, though not flawless: 20% exceeded European microbial limits, and trace levels of certain pesticides were found in two samples.27PubMed Central. Comparative analysis of metals, pesticides, mycotoxins, microbial contaminants and THC potency in illegal and regulated cannabis inflorescences in Canada Heavy metals including arsenic, cadmium, lead, and mercury were also higher in illegal products. For anyone who inhales cannabis, these contaminants go straight into the lungs, making product source a genuine health variable.
Cannabis During Pregnancy and Breastfeeding
THC crosses the placenta and passes into breast milk regardless of how it is consumed. Two systematic reviews have found associations between cannabis use during pregnancy and adverse outcomes including growth restriction, preterm birth, stillbirth, and increased NICU admissions, with heavier use carrying greater risk.28PubMed Central. Marijuana Use in Pregnancy and While Breastfeeding Longer-term longitudinal studies raise concerns about neurobehavioral effects in exposed children, though isolating cannabis from other confounders like alcohol and tobacco use remains a challenge in this research.29Pediatrics. Marijuana Use During Pregnancy and Breastfeeding: Implications for Neonatal and Childhood Outcomes The American Academy of Pediatrics and ACOG both advise against cannabis use during pregnancy and lactation.
How Long Cannabis Stays Detectable
Detection windows depend on your consumption method, frequency, and body composition. For occasional users, urine tests typically turn negative within a few days to a week. For chronic daily users, the picture is dramatically different: THC’s main metabolite has been detected in urine for up to 30 days using laboratory mass spectrometry, and standard immunoassay screening tests have returned positive results for as long as 67 to 93 days after the last use.30PubMed Central. Differentiating new cannabis use from residual urinary cannabinoid excretion in chronic, daily cannabis users The reason is THC’s fat-soluble nature: it accumulates in fatty tissue during regular use and then slowly leaches back into the blood over weeks. This means edibles, which produce especially long-lasting metabolites due to liver processing, may extend detection windows slightly compared to smoking the same total dose.
The Entourage Effect and Why Strain Matters
Cannabis contains over a hundred cannabinoids and dozens of aromatic terpenes, and there is growing evidence that these compounds interact with each other in ways that alter the overall effect. Lab research has found that certain terpenes produce a synergistic activation of CB1 receptors when combined with THC, meaning the effect of the mixture exceeded what you would expect from adding the individual effects together.31PubMed. Selected cannabis terpenes synergize with THC to produce increased CB1 receptor activation Earlier reviews proposed that terpene-cannabinoid interactions could modulate outcomes for pain, anxiety, and inflammation, and that some plant components might even serve as partial antidotes to THC’s intoxicating effects by increasing its therapeutic index.32PubMed Central. Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects This is the scientific basis for why different cannabis strains feel different to users beyond just their THC percentage, though the entourage effect remains an active research area where firm clinical conclusions are still limited.
Harm Reduction Strategies
For people who choose to use cannabis, the evidence supports a few practical steps to lower risk. Updated Lower-Risk Cannabis Use Guidelines recommend delaying first use until after adolescence, avoiding high-potency THC products, keeping frequency and intensity of use low, and choosing non-smoking routes when possible.33PubMed. Lower-Risk Cannabis Use Guidelines (LRCUG) for reducing health harms from non-medical cannabis use: A comprehensive evidence and recommendations update Young people, pregnant women, people who drive, older adults, and those with mental health or cardiovascular conditions are flagged as groups that should exercise particular caution. Choosing legal, regulated products where available substantially reduces the chance of contaminant exposure. And anyone who uses edibles should start with a low dose, wait at least two hours before deciding whether to take more, and store products where children cannot access them.
Impairment and Driving
Cannabis impairs driving ability, but the pattern differs from alcohol in ways that are worth knowing. Research comparing the two substances found that cannabis tends to impair highly automatic driving functions (lane tracking, steady speed maintenance) more than complex tasks requiring conscious control, while alcohol does the opposite.34PubMed Central. The effect of cannabis compared with alcohol on driving Cannabis users also tend to be more aware they are impaired and compensate by driving more slowly and leaving more following distance, something drunk drivers almost never do. Still, that compensatory behavior does not eliminate the risk. The effects of cannabis vary much more between individuals than alcohol’s effects do, because of differences in tolerance, how deeply someone inhales, and how quickly they absorb THC. Epidemiological studies have been less consistent in quantifying the crash-risk increase from cannabis compared to the well-established risk increase from alcohol, but the impairment is real, and combining the two substances is substantially worse than either alone.